GeoVax Labs, Inc

GOVXNASDAQ · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

7.37M

on 2026-06-30, from 92K on 2024-03-31 10-Q ↗

Earlier counts are adjusted for the 1-for-25 reverse split; each bar's tip shows the count as filed.

a raise that quarter, at its price

Newest

None

No S-3 or F-3 shelf on file in the last 30 months.

$12.4M

Agreement of 2024-09-25. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

8.54M

Warrants of every class as tagged in the XBRL facts on 2026-06-30. 10-Q ↗

Cash

0.7 quarters

$3.1M on 2026-06-30 ÷ $4.6M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2026-02-13	Public offering incl. 0.03M pre-funded	432,902	$2.31	$1.0M	424B5 ↗
2026-02-13	Registered direct offering incl. 0.03M pre-funded	432,902	not read	not read	8-K ↗

Also on file: a 1-for-25 reverse split, 2026-01-09 8-K ↗